• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Viruses . Evaluation of an Automated High-Throughput Liquid-Based RNA Extraction Platform on Pooled Nasopharyngeal or Saliva Specimens for SARS-CoV-

tetano

Editor, Senior Moderator
Viruses


. 2021 Apr 2;13(4):615.
doi: 10.3390/v13040615.
Evaluation of an Automated High-Throughput Liquid-Based RNA Extraction Platform on Pooled Nasopharyngeal or Saliva Specimens for SARS-CoV-2 RT-PCR


Allen Wing-Ho Chu[SUP] 1 [/SUP], Cyril Chik-Yan Yip[SUP] 2 [/SUP], Wan-Mui Chan[SUP] 1 [/SUP], Anthony Chin-Ki Ng[SUP] 1 [/SUP], Dream Lok-Sze Chan[SUP] 3 [/SUP], Ryan Ho-Ping Siu[SUP] 3 [/SUP], Cheuk Yiu Tenny Chung[SUP] 3 [/SUP], Jessica Pui-Ling Ng[SUP] 3 [/SUP], Harsha Kittur[SUP] 3 [/SUP], Garrett Lee Mosley[SUP] 3 [/SUP], Rosana Wing-Shan Poon[SUP] 2 [/SUP], Ricky Yin-To Chiu[SUP] 3 [/SUP], Kelvin Kai-Wang To[SUP] 1 2 [/SUP]



Affiliations

Abstract

SARS-CoV-2 RT-PCR with pooled specimens has been implemented during the COVID-19 pandemic as a cost- and manpower-saving strategy for large-scale testing. However, there is a paucity of data on the efficiency of different nucleic acid extraction platforms on pooled specimens. This study compared a novel automated high-throughput liquid-based RNA extraction (LRE) platform (PHASIFY?) with a widely used magnetic bead-based total nucleic acid extraction (MBTE) platform (NucliSENS[SUP]?[/SUP] easyMAG[SUP]?[/SUP]). A total of 60 pools of nasopharyngeal swab and 60 pools of posterior oropharyngeal saliva specimens, each consisting of 1 SARS-CoV-2 positive and 9 SARS-CoV-2 negative specimens, were included for the comparison. Real-time RT-PCR targeting the SARS-CoV-2 RdRp/Hel gene was performed, and GAPDH RT-PCR was used to detect RT-PCR inhibitors. No significant differences were observed in the Ct values and overall RT-PCR positive rates between LRE and MBTE platforms (92.5% (111/120] vs. 90% (108/120]), but there was a slightly higher positive rate for LRE (88.3% (53/60]) than MBTE (81.7% (49/60]) among pooled saliva. The automated LRE method is comparable to a standard MBTE method for the detection of SAR-CoV-2 in pooled specimens, providing a suitable alternative automated extraction platform. Furthermore, LRE may be better suited for pooled saliva specimens due to more efficient removal of RT-PCR inhibitors.

Keywords: COVID-19; RT-PCR; SARS-CoV-2; diagnostics; liquid-based nucleic acid extraction; mass screening; nasopharyngeal swab; pooled specimens; saliva.
 
Back
Top Bottom